Phoenixville, PA, United States of America

Shuqian Xu

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Elan Pharma International Limited, Nanosystems L.l.c.. Active years: 1998-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuqian Xu. Retrieved from https://idiyas.com/inventor/shuqian-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 284(Granted Patents)


Location History:

  • Exton, PA (US) (1998)
  • Phoenixville, PA (US) (2000 - 2001)

Company Filing History:


Years Active: 1998-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Shuqian Xu

Introduction

Shuqian Xu is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for treating human immunodeficiency virus (HIV) infections. With a total of 4 patents to his name, Xu's work has the potential to impact the lives of many individuals affected by HIV.

Latest Patents

Xu's latest patents focus on methods of treating mammals using nanocrystalline formulations of HIV protease inhibitors. The present invention describes formulations of nanoparticulate HIV protease inhibitors that comprise a cellulosic surface stabilizer. These nanoparticulate formulations exhibit an increased rate of dissolution in vitro, an increased rate of absorption in vivo, a decreased fed/fasted ratio variability, and a decreased variability in absorption. The invention also outlines methods for creating these novel formulations, specifically targeting nanoparticulate formulations of HIV type 1 (HIV-1) and type 2 (HIV-2) protease inhibitors.

Career Highlights

Throughout his career, Shuqian Xu has worked with reputable companies such as Elan Pharma International Limited and Nanosystems LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and formulations.

Collaborations

Xu has collaborated with notable professionals in his field, including Sui-Ming Wong and Gary G. Liversidge. These collaborations have likely enhanced his research and development efforts in creating effective treatments for HIV.

Conclusion

Shuqian Xu's innovative work in the field of HIV treatment through nanocrystalline formulations showcases his dedication to improving healthcare solutions. His contributions are significant and reflect the ongoing advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…